NCT02102802View on ClinicalTrials.gov

Exploring Mechanisms of Action in MDMA-assisted Psychotherapy for PTSD

CompletedOBSERVATIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 3, 2015

Study Completion Date

August 3, 2015

Conditions
Posttraumatic Stress Disorder
Interventions
DRUG

Midomafetamine

125, 75, or 30 mg midomafetamine HCl followed 1.5 to 2 hours later by a supplemental dose of midomafetamine HCl half the initial dose

BEHAVIORAL

Therapy

Manualized therapy

Trial Locations (1)

29464-4345

Offices of Michael Mithoefer, Mt. Pleasant

Sponsors

Lead Sponsor

Lykos Therapeutics
All Listed Sponsors
lead

Lykos Therapeutics

INDUSTRY